52
Lawrence Tallon, chief executive at the Medicines and Healthcare products Regulatory Agency (Credit: MHRA)
The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have secured £2 million from Wellcome to continue work on the regulation of digital mental health technologies (DMHTs).
The programme aims to improve outcomes for people with mental health conditions by ensuring that both medical professionals and the public have safe and effective access to DMHTs.
Since launching in 2023, it has focused on introducing clearer, risk-proportionate regulation and evaluation,…